AANS: TLIF is a Cost-Effective Treatment Option

Transforaminal lumbar interbody fusion is a cost-effective treatment option for patients with leg and back pain associated with grade 1 degenerative spondylolisthesis, according to a study presented at the American Association of Neurological Surgeons Annual Meeting.

Advertisement

Researchers assessed both direct and indirect costs related to patients undergoing TLIF. At the two-year follow-up, all patients reported significant improvement from their preoperative levels. The study authors also noted:

•    Patients reported less disability and improved quality of life according to questionnaires they were given.
•    The mean two-year direct medical cost was $25,251.
•    The mean surgical cost was $21,311±2,086, and the mean outpatient resource cost was $3,940±2,720.
•    The average total two-year cost of TLIF was $36,835±11,800.
•    The average reported annual income prior to surgery was $50,000. Patients missed an average of 60 work days, representing a two-year societal cost of $11,584.
•    At two years after surgery, the total cost per Quality Adjusted Life Years gained of TLIF was $42,854, well below the accepted $50,000 cost-effective threshold.

Read the AANS news release on the cost of TLIF (pdf).

Read other coverage on TLIF:

– Performing Minimally Invasive TLIF Procedure: Q&A With Dr. Navin Subramanian of Houston’s Orthopaedic Associates


– Spine Surgery Comparison: Open TLIF Versus Minimal Access TLIF


– Study: TLIF With rhBMP-2 Increases Postoperative Osteolysis Risk

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spine

Advertisement

Comments are closed.